These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

472 related articles for article (PubMed ID: 12850904)

  • 1. In-patient benzodiazepine withdrawal: comparison of fixed and symptom-triggered taper methods.
    McGregor C; Machin A; White JM
    Drug Alcohol Rev; 2003 Jun; 22(2):175-80. PubMed ID: 12850904
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Impaired hypothalamic-pituitary-adrenocortical (HPA) system is related to severity of benzodiazepine withdrawal in patients with depression.
    Wichniak A; Brunner H; Ising M; Pedrosa Gil F; Holsboer F; Friess E
    Psychoneuroendocrinology; 2004 Oct; 29(9):1101-8. PubMed ID: 15219633
    [TBL] [Abstract][Full Text] [Related]  

  • 3. A clinical scale to assess benzodiazepine withdrawal.
    Busto UE; Sykora K; Sellers EM
    J Clin Psychopharmacol; 1989 Dec; 9(6):412-6. PubMed ID: 2574193
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Divalproex sodium in alcohol withdrawal: a randomized double-blind placebo-controlled clinical trial.
    Reoux JP; Saxon AJ; Malte CA; Baer JS; Sloan KL
    Alcohol Clin Exp Res; 2001 Sep; 25(9):1324-9. PubMed ID: 11584152
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Gamma-hydroxybutyric acid (GHB) in the treatment of alcohol withdrawal syndrome: a randomized comparative study versus benzodiazepine.
    Addolorato G; Balducci G; Capristo E; Attilia ML; Taggi F; Gasbarrini G; Ceccanti M
    Alcohol Clin Exp Res; 1999 Oct; 23(10):1596-604. PubMed ID: 10549990
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Symptom severity and quality of life after benzodiazepine withdrawal treatment in participants with complicated dependence.
    Vorma H; Naukkarinen H; Sarna S; Kuoppasalmi K
    Addict Behav; 2004 Aug; 29(6):1059-65. PubMed ID: 15236807
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Double-blind, comparative study of cyamemazine vs. bromazepam in the benzodiazepine withdrawal syndrome.
    Lemoine P; Kermadi I; Garcia-Acosta S; Garay RP; Dib M
    Prog Neuropsychopharmacol Biol Psychiatry; 2006 Jan; 30(1):131-7. PubMed ID: 16243418
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Safety and effectiveness of a fixed-dose phenobarbital protocol for inpatient benzodiazepine detoxification.
    Kawasaki SS; Jacapraro JS; Rastegar DA
    J Subst Abuse Treat; 2012 Oct; 43(3):331-4. PubMed ID: 22285834
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Benzodiazepine tapering: a prospective study.
    Vikander B; Koechling UM; Borg S; Tönne U; Hiltunen AJ
    Nord J Psychiatry; 2010 Aug; 64(4):273-82. PubMed ID: 20629611
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Comparison of buprenorphine and methadone in the treatment of opiate withdrawal: possible advantages of buprenorphine for the treatment of opiate-benzodiazepine codependent patients?
    Reed LJ; Glasper A; de Wet CJ; Bearn J; Gossop M
    J Clin Psychopharmacol; 2007 Apr; 27(2):188-92. PubMed ID: 17414244
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Dependence on benzodiazepines. Clinical and biological aspects].
    Pelissolo A; Bisserbe JC
    Encephale; 1994; 20(2):147-57. PubMed ID: 7914165
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The role of captodiamine in the withdrawal from long-term benzodiazepine treatment.
    Mercier-Guyon C; Chabannes JP; Saviuc P
    Curr Med Res Opin; 2004 Sep; 20(9):1347-55. PubMed ID: 15383182
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Benzodiazepine co-dependence exacerbates the opiate withdrawal syndrome.
    de Wet C; Reed L; Glasper A; Moran P; Bearn J; Gossop M
    Drug Alcohol Depend; 2004 Oct; 76(1):31-5. PubMed ID: 15380286
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Intravenous flumazenil versus oxazepam tapering in the treatment of benzodiazepine withdrawal: a randomized, placebo-controlled study.
    Gerra G; Zaimovic A; Giusti F; Moi G; Brewer C
    Addict Biol; 2002 Oct; 7(4):385-95. PubMed ID: 14578014
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Predictors of long-term benzodiazepine abstinence in participants of a randomized controlled benzodiazepine withdrawal program.
    Voshaar RC; Gorgels WJ; Mol AJ; van Balkom AJ; Mulder J; van de Lisdonk EH; Breteler MH; Zitman FG
    Can J Psychiatry; 2006 Jun; 51(7):445-52. PubMed ID: 16838826
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Benzodiazepine loading versus symptom-triggered treatment of alcohol withdrawal: a prospective, randomized clinical trial.
    Maldonado JR; Nguyen LH; Schader EM; Brooks JO
    Gen Hosp Psychiatry; 2012; 34(6):611-7. PubMed ID: 22898443
    [TBL] [Abstract][Full Text] [Related]  

  • 17. A Symptom-Triggered Benzodiazepine Protocol Utilizing SAS and CIWA-Ar Scoring for the Treatment of Alcohol Withdrawal Syndrome in the Critically Ill.
    Sen S; Grgurich P; Tulolo A; Smith-Freedman A; Lei Y; Gray A; Dargin J
    Ann Pharmacother; 2017 Feb; 51(2):101-110. PubMed ID: 27733668
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Severe Benzodiazepine Use Disorder in a 16-Year-Old Adolescent: A Rapid and Safe Inpatient Taper.
    Fournier C; Jamoulle O; Chadi A; Chadi N
    Pediatrics; 2021 Jan; 147(1):. PubMed ID: 33361358
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Benzodiazepine withdrawal seizures and management.
    Hu X
    J Okla State Med Assoc; 2011 Feb; 104(2):62-5. PubMed ID: 21815323
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Self-reported sleep, sleepiness, and repeated alcohol withdrawals: a randomized, double blind, controlled comparison of lorazepam vs gabapentin.
    Malcolm R; Myrick LH; Veatch LM; Boyle E; Randall PK
    J Clin Sleep Med; 2007 Feb; 3(1):24-32. PubMed ID: 17557449
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 24.